Monitora più quotazioni in tempo reale dalle principali borse, come Borsa Italiana, NASDAQ, NYSE, AMEX, Bovespa e altro ancora.
bioAffinity Technologies Inc addresses the need for noninvasive diagnosis of early-stage cancer and diseases of the lung and targeted cancer treatment. It develops proprietary noninvasive diagnostic tests and cancer therapeutics using technology that preferentially targets cancer cells and cell popu... bioAffinity Technologies Inc addresses the need for noninvasive diagnosis of early-stage cancer and diseases of the lung and targeted cancer treatment. It develops proprietary noninvasive diagnostic tests and cancer therapeutics using technology that preferentially targets cancer cells and cell populations indicative of a diseased state. The company is involved in developing technologies that, in the future, will be able to detect and monitor diseases of the lung and other cancers and treat many cancers. Mostra di più
| Periodo † | Var | Var % | Apert. | Max | Min | Med. Vol. Giorn. | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | 0.0099 | 2.00526635609 | 0.4937 | 0.5353 | 0.4602 | 166411 | 0.49937061 | CS |
| 4 | -0.1863 | -27.0039136107 | 0.6899 | 1.551 | 0.4602 | 28262874 | 1.06903318 | CS |
| 12 | -0.2064 | -29.0704225352 | 0.71 | 1.551 | 0.2404 | 10105432 | 1.00323593 | CS |
| 26 | -0.8464 | -62.6962962963 | 1.35 | 1.551 | 0.2404 | 4854824 | 1.00185428 | CS |
| 52 | -1.8564 | -78.6610169492 | 2.36 | 2.9893 | 0.2404 | 2458929 | 1.02477505 | CS |
| 156 | -7.8964 | -94.0047619048 | 8.4 | 15.55 | 0.2404 | 1310011 | 1.87082339 | CS |
| 260 | -7.8964 | -94.0047619048 | 8.4 | 15.55 | 0.2404 | 1310011 | 1.87082339 | CS |
Le azioni che visualizzerai appariranno in questo riquadro, così potrai facilmente tornare alle quotazioni di tuo interesse.
Assistenza: support@advfn.it
Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni
Caratteristiche principali
Premium
